LS Polaris Innovation Fund

LS Polaris Innovation Fund is a venture capital fund managed by Polaris Partners, dedicated to accelerating the commercial and therapeutic potential of early-stage academic research. By partnering with passionate entrepreneurs possessing transformational science, the fund fosters company creation and growth through an active investment model. The team brings decades of experience in healthcare investing and entrepreneurship to guide early-stage companies.

The fund's strategy involves collaborating with innovators to translate academic research into viable healthcare solutions. It focuses on sectors such as biotechnology, life sciences, and healthcare, investing across various stages from seed to pre-IPO. The team comprises experts in scientific research, biopharma, and venture capital, all committed to bringing biomedical innovation to the market.

LS Polaris Innovation Fund operates under the management of LS Polaris Innovation Fund Management, L.L.C., an affiliate of Polaris Partners. The fund's leadership includes Managing Partners Amy Schulman and Ellie McGuire, who bring extensive experience in healthcare investing and entrepreneurship. The fund's portfolio includes companies like SQZ Biotech and Lyndra Therapeutics, reflecting its commitment to advancing innovative healthcare solutions.